A recent retrospective cohort found (Ga-PSMA-11, 18F-PSMA, or 18F-DCFPyL) PSMA-avid thyroid gland lesions in 1.1% of patients undergoing PSMA PET evaluation for PCa; of these, a small but clinically significant proportion (3 of 61) were malignant, with one differentiated thyroid carcinoma, one Hürthle cell carcinoma and one renal cell carcinoma metastasis31. Here, FOLH1 is linked to hereditary clear cell renal cell carcinoma.